Clinical Trial Update: Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus [Phase 3]

View source ↗

Summary

Open-label Phase 3 long-term study to evaluate safety, tolerability, and efficacy of Neramexane in adults with subjective tinnitus; the trial status is terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinnitus

Drugs mentioned

• Neramexane (neramexane)

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Subjective Tinnitus | Phase 3 | Status: TERMINATED